We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Metabolon Receives CLIA Certificate of Registration
News

Metabolon Receives CLIA Certificate of Registration

Metabolon Receives CLIA Certificate of Registration
News

Metabolon Receives CLIA Certificate of Registration

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Metabolon Receives CLIA Certificate of Registration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The CLIA registration allows Metabolon’s clinical laboratory to perform high-complexity tests on patient samples. Later this year, the company plans to launch tests for insulin resistance and urological cancers based upon biochemical biomarkers the company discovered using its proprietary metabolomic profiling technology platform.

John Ryals, Metabolon’s president and chief executive officer said, “CLIA certification is an important step in our strategy to derive further economic value from our sophisticated approach to biomarker discovery while advancing our plans to fulfill the promise of personalized medicine.”

Advertisement